nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Chlorambucil—GSTP1—chronic obstructive pulmonary disease	0.032	0.851	CrCbGaD
Melphalan—SLC7A5—respiratory system—chronic obstructive pulmonary disease	0.0184	0.162	CbGeAlD
Melphalan—SLC7A5—connective tissue—chronic obstructive pulmonary disease	0.0162	0.143	CbGeAlD
Melphalan—SLC7A5—bronchus—chronic obstructive pulmonary disease	0.0151	0.134	CbGeAlD
Melphalan—SLC7A5—smooth muscle tissue—chronic obstructive pulmonary disease	0.0148	0.131	CbGeAlD
Melphalan—SLC7A5—trachea—chronic obstructive pulmonary disease	0.0136	0.12	CbGeAlD
Melphalan—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.01	0.0888	CbGeAlD
Melphalan—SLC7A5—lung—chronic obstructive pulmonary disease	0.00975	0.0863	CbGeAlD
Melphalan—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00918	0.0812	CbGeAlD
Melphalan—SLC7A5—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00826	0.506	CbGdCrCtD
Melphalan—SLC7A5—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00806	0.494	CbGdCrCtD
Melphalan—SLC22A3—lung—chronic obstructive pulmonary disease	0.00605	0.0535	CbGeAlD
Melphalan—Ibuprofen—CXCL8—chronic obstructive pulmonary disease	0.00445	0.118	CrCbGaD
Melphalan—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00368	0.00441	CcSEcCtD
Melphalan—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00368	0.00441	CcSEcCtD
Melphalan—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.00366	0.00439	CcSEcCtD
Melphalan—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00365	0.00438	CcSEcCtD
Melphalan—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00364	0.00437	CcSEcCtD
Melphalan—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00364	0.00437	CcSEcCtD
Melphalan—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00363	0.00436	CcSEcCtD
Melphalan—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00361	0.00434	CcSEcCtD
Melphalan—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00361	0.00433	CcSEcCtD
Melphalan—Arrhythmia—Aminophylline—chronic obstructive pulmonary disease	0.00351	0.00421	CcSEcCtD
Melphalan—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00347	0.00417	CcSEcCtD
Melphalan—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00347	0.00417	CcSEcCtD
Melphalan—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00335	0.00402	CcSEcCtD
Melphalan—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00334	0.00401	CcSEcCtD
Melphalan—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00333	0.00399	CcSEcCtD
Melphalan—Arrhythmia—Tiotropium—chronic obstructive pulmonary disease	0.00331	0.00397	CcSEcCtD
Melphalan—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00331	0.00397	CcSEcCtD
Melphalan—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.0032	0.00384	CcSEcCtD
Melphalan—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00318	0.00382	CcSEcCtD
Melphalan—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.00317	0.0038	CcSEcCtD
Melphalan—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00309	0.00371	CcSEcCtD
Melphalan—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00308	0.0037	CcSEcCtD
Melphalan—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00308	0.0037	CcSEcCtD
Melphalan—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00307	0.00368	CcSEcCtD
Melphalan—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00307	0.00368	CcSEcCtD
Melphalan—Neuropathy—Prednisolone—chronic obstructive pulmonary disease	0.00303	0.00364	CcSEcCtD
Melphalan—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.003	0.00361	CcSEcCtD
Melphalan—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00296	0.00356	CcSEcCtD
Melphalan—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00295	0.00355	CcSEcCtD
Melphalan—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00295	0.00355	CcSEcCtD
Melphalan—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00353	CcSEcCtD
Melphalan—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00353	CcSEcCtD
Melphalan—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00293	0.00352	CcSEcCtD
Melphalan—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00293	0.00352	CcSEcCtD
Melphalan—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.00293	0.00352	CcSEcCtD
Melphalan—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00289	0.00347	CcSEcCtD
Melphalan—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00288	0.00346	CcSEcCtD
Melphalan—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00287	0.00345	CcSEcCtD
Melphalan—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00286	0.00344	CcSEcCtD
Melphalan—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00284	0.00341	CcSEcCtD
Melphalan—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00282	0.00339	CcSEcCtD
Melphalan—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00282	0.00338	CcSEcCtD
Melphalan—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00279	0.00335	CcSEcCtD
Melphalan—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00335	CcSEcCtD
Melphalan—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00278	0.00333	CcSEcCtD
Melphalan—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00277	0.00333	CcSEcCtD
Melphalan—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00332	CcSEcCtD
Melphalan—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00275	0.0033	CcSEcCtD
Melphalan—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00275	0.0033	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00273	0.00327	CcSEcCtD
Melphalan—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00273	0.00327	CcSEcCtD
Melphalan—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.0027	0.00324	CcSEcCtD
Melphalan—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.0027	0.00324	CcSEcCtD
Melphalan—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.0027	0.00324	CcSEcCtD
Melphalan—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.0027	0.00324	CcSEcCtD
Melphalan—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00267	0.00321	CcSEcCtD
Melphalan—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00267	0.00321	CcSEcCtD
Melphalan—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.00267	0.0032	CcSEcCtD
Melphalan—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00266	0.0032	CcSEcCtD
Melphalan—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00266	0.0032	CcSEcCtD
Melphalan—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00265	0.00318	CcSEcCtD
Melphalan—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00264	0.00317	CcSEcCtD
Melphalan—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00264	0.00317	CcSEcCtD
Melphalan—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00264	0.00317	CcSEcCtD
Melphalan—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00263	0.00316	CcSEcCtD
Melphalan—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00262	0.00315	CcSEcCtD
Melphalan—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00262	0.00314	CcSEcCtD
Melphalan—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00261	0.00313	CcSEcCtD
Melphalan—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00257	0.00309	CcSEcCtD
Melphalan—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00256	0.00307	CcSEcCtD
Melphalan—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00306	CcSEcCtD
Melphalan—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00306	CcSEcCtD
Melphalan—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.00252	0.00303	CcSEcCtD
Melphalan—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00249	0.00299	CcSEcCtD
Melphalan—Ulcer—Prednisone—chronic obstructive pulmonary disease	0.00248	0.00297	CcSEcCtD
Melphalan—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00246	0.00295	CcSEcCtD
Melphalan—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00243	0.00291	CcSEcCtD
Melphalan—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.0024	0.00288	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.0024	0.00288	CcSEcCtD
Melphalan—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00284	CcSEcCtD
Melphalan—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00232	0.00278	CcSEcCtD
Melphalan—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.00273	CcSEcCtD
Melphalan—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00227	0.00273	CcSEcCtD
Melphalan—Cough—Formoterol—chronic obstructive pulmonary disease	0.00227	0.00273	CcSEcCtD
Melphalan—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00224	0.00269	CcSEcCtD
Melphalan—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.00223	0.00267	CcSEcCtD
Melphalan—Cough—Montelukast—chronic obstructive pulmonary disease	0.00223	0.00267	CcSEcCtD
Melphalan—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00222	0.00266	CcSEcCtD
Melphalan—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00266	CcSEcCtD
Melphalan—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00266	CcSEcCtD
Melphalan—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00222	0.00266	CcSEcCtD
Melphalan—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00222	0.00266	CcSEcCtD
Melphalan—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00221	0.00265	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.00264	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.0022	0.00264	CcSEcCtD
Melphalan—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.0022	0.00264	CcSEcCtD
Melphalan—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00217	0.00261	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00259	CcSEcCtD
Melphalan—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00258	CcSEcCtD
Melphalan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00255	CcSEcCtD
Melphalan—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00255	CcSEcCtD
Melphalan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00255	CcSEcCtD
Melphalan—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00255	CcSEcCtD
Melphalan—Infection—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00253	CcSEcCtD
Melphalan—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00253	CcSEcCtD
Melphalan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00251	CcSEcCtD
Melphalan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00251	CcSEcCtD
Melphalan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00209	0.00251	CcSEcCtD
Melphalan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00208	0.0025	CcSEcCtD
Melphalan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00208	0.0025	CcSEcCtD
Melphalan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00249	CcSEcCtD
Melphalan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00249	CcSEcCtD
Melphalan—Infection—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00248	CcSEcCtD
Melphalan—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00248	CcSEcCtD
Melphalan—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00248	CcSEcCtD
Melphalan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00206	0.00247	CcSEcCtD
Melphalan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00204	0.00245	CcSEcCtD
Melphalan—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00202	0.00243	CcSEcCtD
Melphalan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00241	CcSEcCtD
Melphalan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.00241	CcSEcCtD
Melphalan—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00239	CcSEcCtD
Melphalan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00199	0.00238	CcSEcCtD
Melphalan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00199	0.00238	CcSEcCtD
Melphalan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00237	CcSEcCtD
Melphalan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00196	0.00235	CcSEcCtD
Melphalan—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00234	CcSEcCtD
Melphalan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00194	0.00233	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00194	0.00232	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00194	0.00232	CcSEcCtD
Melphalan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00191	0.0023	CcSEcCtD
Melphalan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00191	0.00229	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.0019	0.00228	CcSEcCtD
Melphalan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00189	0.00227	CcSEcCtD
Melphalan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00189	0.00227	CcSEcCtD
Melphalan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00188	0.00225	CcSEcCtD
Melphalan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00187	0.00225	CcSEcCtD
Melphalan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00187	0.00225	CcSEcCtD
Melphalan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00224	CcSEcCtD
Melphalan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00186	0.00224	CcSEcCtD
Melphalan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00183	0.0022	CcSEcCtD
Melphalan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.0022	CcSEcCtD
Melphalan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00183	0.0022	CcSEcCtD
Melphalan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00183	0.0022	CcSEcCtD
Melphalan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.0022	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00219	CcSEcCtD
Melphalan—Pain—Formoterol—chronic obstructive pulmonary disease	0.00182	0.00218	CcSEcCtD
Melphalan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.00218	CcSEcCtD
Melphalan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00216	CcSEcCtD
Melphalan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00216	CcSEcCtD
Melphalan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00179	0.00215	CcSEcCtD
Melphalan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00215	CcSEcCtD
Melphalan—Pain—Montelukast—chronic obstructive pulmonary disease	0.00178	0.00214	CcSEcCtD
Melphalan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00178	0.00213	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00177	0.00212	CcSEcCtD
Melphalan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00212	CcSEcCtD
Melphalan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00211	CcSEcCtD
Melphalan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00211	CcSEcCtD
Melphalan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.00209	CcSEcCtD
Melphalan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00208	CcSEcCtD
Melphalan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00208	CcSEcCtD
Melphalan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00206	CcSEcCtD
Melphalan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00203	CcSEcCtD
Melphalan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00203	CcSEcCtD
Melphalan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00201	CcSEcCtD
Melphalan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00166	0.00199	CcSEcCtD
Melphalan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00166	0.00199	CcSEcCtD
Melphalan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00166	0.00199	CcSEcCtD
Melphalan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00165	0.00198	CcSEcCtD
Melphalan—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00163	0.00195	CcSEcCtD
Melphalan—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00162	0.00194	CcSEcCtD
Melphalan—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00162	0.00194	CcSEcCtD
Melphalan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00191	CcSEcCtD
Melphalan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00188	CcSEcCtD
Melphalan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00188	CcSEcCtD
Melphalan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.00188	CcSEcCtD
Melphalan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00153	0.00184	CcSEcCtD
Melphalan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00183	CcSEcCtD
Melphalan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00183	CcSEcCtD
Melphalan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.0015	0.0018	CcSEcCtD
Melphalan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.0018	CcSEcCtD
Melphalan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00149	0.00179	CcSEcCtD
Melphalan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00177	CcSEcCtD
Melphalan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00177	CcSEcCtD
Melphalan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00175	CcSEcCtD
Melphalan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00175	CcSEcCtD
Melphalan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.00174	CcSEcCtD
Melphalan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00173	CcSEcCtD
Melphalan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00171	CcSEcCtD
Melphalan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.0017	CcSEcCtD
Melphalan—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00138	0.00165	CcSEcCtD
Melphalan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00165	CcSEcCtD
Melphalan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00162	CcSEcCtD
Melphalan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00162	CcSEcCtD
Melphalan—Rash—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00161	CcSEcCtD
Melphalan—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00161	CcSEcCtD
Melphalan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00161	CcSEcCtD
Melphalan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00161	CcSEcCtD
Melphalan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00159	CcSEcCtD
Melphalan—Rash—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00158	CcSEcCtD
Melphalan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00157	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00154	CcSEcCtD
Melphalan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00153	CcSEcCtD
Melphalan—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00152	CcSEcCtD
Melphalan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00152	CcSEcCtD
Melphalan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00152	CcSEcCtD
Melphalan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00152	CcSEcCtD
Melphalan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00124	0.00148	CcSEcCtD
Melphalan—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00122	0.00147	CcSEcCtD
Melphalan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00143	CcSEcCtD
Melphalan—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00142	CcSEcCtD
Melphalan—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00118	0.00141	CcSEcCtD
Melphalan—Ibuprofen—ALB—chronic obstructive pulmonary disease	0.00116	0.0308	CrCbGaD
Melphalan—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00139	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00138	CcSEcCtD
Melphalan—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00115	0.00138	CcSEcCtD
Melphalan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00135	CcSEcCtD
Melphalan—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00131	CcSEcCtD
Melphalan—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00128	CcSEcCtD
Melphalan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00126	CcSEcCtD
Melphalan—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00125	CcSEcCtD
Melphalan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00124	CcSEcCtD
Melphalan—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000984	0.00118	CcSEcCtD
Melphalan—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000947	0.00114	CcSEcCtD
Melphalan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000914	0.0011	CcSEcCtD
Melphalan—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000888	0.00107	CcSEcCtD
Melphalan—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000872	0.00105	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000866	0.00104	CcSEcCtD
Melphalan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000848	0.00102	CcSEcCtD
Melphalan—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000836	0.001	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000836	0.001	CcSEcCtD
Melphalan—Infection—Prednisone—chronic obstructive pulmonary disease	0.000831	0.000997	CcSEcCtD
Melphalan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000816	0.00098	CcSEcCtD
Melphalan—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000812	0.000975	CcSEcCtD
Melphalan—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000797	0.000957	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000762	0.000915	CcSEcCtD
Melphalan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000751	0.000901	CcSEcCtD
Melphalan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000736	0.000884	CcSEcCtD
Melphalan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000727	0.000873	CcSEcCtD
Melphalan—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000726	0.000871	CcSEcCtD
Melphalan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000725	0.00087	CcSEcCtD
Melphalan—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000721	0.000866	CcSEcCtD
Melphalan—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000684	0.000821	CcSEcCtD
Melphalan—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000664	0.000798	CcSEcCtD
Melphalan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000616	0.00074	CcSEcCtD
Melphalan—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.0006	0.00072	CcSEcCtD
Melphalan—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000592	0.00071	CcSEcCtD
Melphalan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000572	0.000687	CcSEcCtD
Melphalan—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000532	0.000638	CcSEcCtD
Melphalan—Rash—Prednisone—chronic obstructive pulmonary disease	0.000527	0.000633	CcSEcCtD
Melphalan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000527	0.000632	CcSEcCtD
Melphalan—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000497	0.000596	CcSEcCtD
